Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a common malignancy with poor prognosis. In recent years, immune checkpoint inhibitors (ICIs) have enabled breakthroughs in the clinical treatment of patients with HCC, but the overall response rate to ICIs in HCC patients is still low, and no validated biomarker is...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
格式: | 圖書 |
出版: |
Elsevier,
2024-03-01T00:00:00Z.
|
主題: | |
在線閱讀: | Connect to this object online. |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
因特網
Connect to this object online.3rd Floor Main Library
索引號: |
A1234.567 |
---|---|
復印件 1 | 可用 |